Results 71 to 80 of about 21,988 (154)

Metabolic Reprogramming in Stromal and Immune Cells in Rheumatoid Arthritis and Osteoarthritis: Therapeutic Possibilities

European Journal of Immunology, Volume 55, Issue 4, April 2025.
Immune cells and stromal cells undergo metabolic reprogramming in both rheumatoid and osteoarthritis. This review summarises current evidence on the metabolic changes within and the crosstalk between immune and stromal cells in these diseases. In addition, we explore the therapeutic potential of targeting metabolic processes for the treatment of ...
Órlaith C. Henry, Luke A. J. O'Neill
wiley   +1 more source

A case-control study of anaemia in patients with rheumatoid arthritis treated with disease-modifying antirheumatic drugs in an adult population in the US: prevalence and impact on healthcare utilisation [PDF]

, 2008
Chenglong Han, N. Zhao, Mahboob U. Rahman, Mittie K. Doyle, Mohan Bala   +4 more
openalex   +1 more source

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

Immunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi, Hamad Abdel Hadi, Masautso Chaponda, Reem El Ajez, Mohamed Ataelmanan, Sief Khasawneh, Hind Saqallah, Maisa Ali, Nabeel Abdulla, Javed Iqbal, Ali S. Omrani, Muna Al Maslamani, Abdullatif Al‐Khal   +12 more
wiley   +1 more source

Rheumatoid Atlantoaxial Subluxation Can Be Prevented by Intensive Use of Traditional Disease Modifying Antirheumatic Drugs [PDF]

, 2009
Markku Kauppi, Marko H. Neva, Kari Laiho, Hannu Kautiainen, Reijo Luukkainen, Anna Karjalainen, Pekka Hannonen, Marjatta Leirisalo‐Repo, Markku Korpela, Kirsti Ilva, Timo Möttönen   +10 more
openalex   +1 more source

Recent Developments in the Antimicrobial Efficacy of Coinage Metal (Cu, Ag, and Au) N‐Heterocyclic Carbene Complexes

ChemistrySelect, Volume 10, Issue 14, April 11, 2025.
N‐heterocyclic carbenes (NHCs) exhibit promising biological activity, which can be enhanced by coordination with coinage metals. This review explores the antimicrobial activity of azolium salts and their corresponding NHC complexes of Ag, Au, and Cu. Silver(I)‐NHC complexes are the more prominent biologically active compounds.
Ngonidzashe Ruwizhi, Thishana Singh, Bernard Omondi, Muhammad D. Bala   +3 more
wiley   +1 more source

Initiation of Disease-Modifying Antirheumatic Drugs in Older Medicare Beneficiaries With New Diagnosis of Late-Onset Rheumatoid Arthritis. [PDF]

ACR Open Rheumatol, 2023
Lee J, Martindale J, Makris UE, Singh N, Yung R, Bynum JPW.   +5 more
europepmc   +1 more source

Efficacy of granulocyte and monocyte adsorptive apheresis on skin and joint manifestations of palmoplantar pustulosis with pustulotic arthro‐osteitis: A multicentric, prospective, observational study

The Journal of Dermatology, Volume 52, Issue 4, Page 642-650, April 2025.
Abstract Granulocyte and monocyte adsorptive apheresis (GMA) selectively removes activated granulocytes and monocytes from the peripheral blood. In 2012, GMA was approved in Japan as a treatment for generalized pustular psoriasis and localized pustular psoriasis or palmoplantar pustulosis (PPP).
Namiko Abe, Yuko Higashi, Chiharu Tateishi, Takuro Kanekura, Daisuke Tsuruta, Tomoko Kobayashi, Yukari Okubo   +6 more
wiley   +1 more source

Efficacy and toxicity of old and new disease modifying antirheumatic drugs

, 2000
Peter Tugwell
openalex   +1 more source

Plasma Adiponectin in Patients with Active, Early, and Chronic Rheumatoid Arthritis Who Are Steroid- and Disease-Modifying Antirheumatic Drug-Naive Compared with Patients with Osteoarthritis and Controls [PDF]

, 2009
Trine Bay Laurberg, Jan Frystyk, Torkell Ellingsen, Ib Tønder Hansen, Anette Jørgensen, Ulrik Tarp, Merete Lund Hetland, Kim Hørslev‐Petersen, Nete Hornung, Jørgen Poulsen, Allan Flyvbjerg, Kristian Stengaard‐Pedersen   +11 more
openalex   +1 more source

Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021)

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 4, Page 707-719, April 2025.
In Switzerland, most dispensed medications with teratogenic effect debated or proven were in the group of weak teratogenicity level. Reassuringly, many women discontinue treatment with potential teratogens before pregnancy. Abstract Introduction Exposure to potentially teratogenic medications during pregnancy is underinvestigated in Switzerland.
Carole A. Marxer, Sereina M. Graber, Daniel Surbek, Alice Panchaud, Christoph R. Meier, Julia Spoendlin   +5 more
wiley   +1 more source